H-scan,Shear Wave and Bioluminescent Assessment of the Progression of Pancreatic Cancer Metastases in the Liver |
| |
Affiliation: | 2. Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA;2. Department of Bioengineering, University of Texas at Dallas, Richardson, TX, USA;3. Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA;2. Department of Mechanical Engineering, University of Rochester, Rochester, New York, USA;3. Pfizer Inc., Cambridge, Massachusetts, USA |
| |
Abstract: | The non-invasive quantification of tumor burden and the response to therapies remain an important objective for imaging modalities. To characterize the performance of two newly optimized ultrasound-based analyses, we applied shear wave and H-scan scattering analyses to repeated trans-abdominal ultrasound scans of a murine model of metastatic pancreatic cancer. In addition, bioluminescence measurements were obtained as an alternative reference. The tumor metastases grow aggressively and result in death at approximately 4 wk if untreated, but longer for those treated with chemotherapy. We found that our three imaging methods (shear wave speed, H-scan, bioluminescence) trended toward increasing output measures with time during tumor growth, and these measures were delayed for the group receiving chemotherapy. The relative sensitivity of H-scan tracked closely with bioluminescence measurements, particularly in the early to mid-stages of tumor growth. The correlation between H-scan and bioluminescence was found to be strong, with a Spearman's rank correlation coefficient greater than 0.7 across the entire series. These preliminary results suggest that non-invasive ultrasound imaging analyses are capable of tracking the response of tumor models to therapeutic agents. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|